Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Int Assoc Provid AIDS Care ; 14(2): 116-9, 2015.
Article in English | MEDLINE | ID: mdl-25361558

ABSTRACT

Pharmacokinetics of lamivudine (3TC)/zidovudine (ZDV) and lopinavir/ritonavir (LPV/r) are described in a gravid 27-year-old HIV-infected woman with gastric bypass. Blood levels were obtained for these medications at time points 0 (predose) and 1, 2, 4, 6, 8, and 12 hours postdose. For these times, the levels (µg/mL) of 3TC were 0.0801, 0.69, 0.339, 0.237, 0.202, 0.108, and 0.0461; the levels of ZDV were 0.0153, 0.433, 0.0717, 0.0481, 0.0107, 0.0214, and 0.00864; the levels of lopinavir (LPV) were 2.45, 2.64, 1.95, 2.78, 3.83, 3.20, and 1.92; and the levels of ritonavir (RTV) were 0.09, 0.10, 0.07, 0.11, 0.15, 0.15, and 0.06. These data suggest that gastric bypass affected these antiretroviral drug levels. A functional, intact small bowel is responsible for absorption of these medications.


Subject(s)
Anti-HIV Agents/therapeutic use , HIV Infections/drug therapy , Lamivudine/therapeutic use , Lopinavir/therapeutic use , Pregnancy Complications, Infectious/drug therapy , Pregnancy Trimester, Third/blood , Ritonavir/therapeutic use , Zidovudine/therapeutic use , Adult , Anti-HIV Agents/blood , Drug Combinations , Female , Gastric Bypass , HIV Infections/blood , Humans , Lamivudine/blood , Lopinavir/blood , Pregnancy , Pregnancy Complications, Infectious/blood , Pregnancy Complications, Infectious/surgery , Ritonavir/blood , Zidovudine/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...